1-4 of 4
Efstathios Kastritis, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Interaction of Bortezomib with P-Gp, MRP-1 and BCRP Drug Transporters: Implications for Therapeutic Applications of Bortezomib in Advanced Multiple Myeloma and Other Neoplasias.

Melissa G Ooi, M.D., Robert O'Connor, Ph.D, Jana Jakubikova, Ph.D, Justine Meiller, Diploma, in, Biochemistry, Degre, Steffen Klippel, Ph.D, Jake Delmore, Efstathios Kastritis, M.D, Douglas McMillin, Ph.D, Martin Clynes, Ph.D, Paul Richardson, M.D., Constantine S. Mitsiades, M.D., Ph.D, Peter O'Gorman, M.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2009) 114 (22): 1729.
https://doi.org/10.1182/blood.V114.22.1729.1729
Published: 2009
Journal Articles

Prognostic Significance of Magnetic Resonance Imaging (MRI) of Bone Marrow (BM) in Patients with Multiple Myeloma (MM) Undergoing Treatment with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplantation (ASCT).

Athanasios Anagnostopoulos, MD, Lia A. Moulopoulos, M.D., Maria Roussou, M.D., Efstathios Kastritis, M.D., Dimitra Gika, George Bozas, M.D., Aikaterini Stefanoudaki, M.D., Nikolaos Anagnostopoulos, M.D., Amalia Vassou, M.D., Konstantinos Bourantas, M.D., Meletios A. Dimopoulos, M.D.
Journal: Blood
Blood (2006) 108 (11): 3095.
https://doi.org/10.1182/blood.V108.11.3095.3095
Published: 2006
Journal Articles

Renal Failure in Multiple Myeloma: Incidence, Correlations and Prognostic Significance.

Vangelis Eleftherakis-Papaiakovou, MD, Athanasios Anagnostopoulos, M.D., Aristotelis Bamias, M.D., Dimitra Gika, Argiris Symeonidis, M.D., Anastasia Pouli, M.D., Nikolaos Anagnostopoulos, M.D., Konstantinos Zervas, M.D., Evridiki Michali, M.D., Efstathios Kastritis, M.D., Meletios A. Dimopoulos, M.D.
Journal: Blood
Blood (2006) 108 (11): 5000.
https://doi.org/10.1182/blood.V108.11.5000.5000
Published: 2006
Journal Articles

Angiogenic Cytokines Are Increased in the Serum of Patients with Waldenastrom’s Macroglobulinemia (WM): Correlations with Clinical Data.

Athanasios Anagnostopoulos, MD, Evangelos Terpos, M.D., Konstantinos Zervas, M.D., Efstathios Kastritis, M.D., Vangelis Eleftherakis-Papaiakovou, M.D., Irini Katodritou, M.D., Konstantinos Tsionos, M.D., Meletios A. Dimopoulos, M.D.
Journal: Blood
Blood (2006) 108 (11): 5006.
https://doi.org/10.1182/blood.V108.11.5006.5006
Published: 2006